People

Found 59,974 articles

• BioInvent Strengthens Management with Appointment of Ingunn Munch Lindvig as Senior Vice President Regulatory Affairs

  5/23/2023

  BioInvent International AB announces the appointment of Ingunn Munch Lindvig as Senior Vice President Regulatory Affairs.

• Veristat Taps Accomplished Industry Leaders to Support Growth and Innovation

  5/23/2023

  Veristat, a scientific-minded global clinical research organization and regulatory consultancy, shared the addition of three seasoned leaders to Veristat’s Executive team.

• BioAge Labs Appoints BJ Sullivan as Chief Strategy Officer

  5/22/2023

  BioAge Labs, Inc., a clinical-stage biotechnology company developing therapeutics that target the molecular causes of aging to extend healthy human lifespan, announced the appointment of BJ Sullivan, Ph.D., as Chief Strategy Officer.

• The Foundation for the National Institutes of Health Announces the Appointment of Jay Bradner, M.D. and Jim Weiss to the Board of Directors

  5/22/2023

  The Foundation for the National Institutes of Health is proud to announce two new additions to the FNIH Board of Directors, Dr. Jay Bradner and Jim Weiss.

• Gamida Cell Appoints Terry Coelho as CFO

  5/22/2023

  Gamida Cell Ltd. today announced the appointment of Terry Coelho as Chief Financial Officer effective immediately.

• Quantum-Si Appoints Life Sciences and Diagnostics Industry Leader Jack Kenny to its Board of Directors

  5/22/2023

  Quantum-Si Incorporated today announced the appointment of Jack Kenny, CEO of Meridian Bioscience, Inc., to its Board of Directors.

• Avalo Announces Appointment of Michael Croft, Ph.D. and Jeff Edelson, M.D. to its Scientific Advisory Board

  5/22/2023

  Avalo Therapeutics, Inc. (Nasdaq: AVTX) announced the appointment of Dr. Michael Croft and Dr. Jeff Edelson to the company’s Scientific Advisory Board (SAB).

• Potrero Medical welcomes The Honorable David Shulkin, M.D. Former U.S. Secretary of Veterans Affairs, to their Advisory Board

  5/22/2023

  Potrero Medical announced today that Secretary Shulkin has joined its advisory board, he is a healthcare leader and policy expert with over 20 years of experience in both private and government sectors.

• Robert J. Coury to Transition from Executive Chairman of Viatris to Chairman Emeritus and Senior Strategic Advisor to the Board and Management at the End of the Year

  5/22/2023

  Viatris Inc. Robert J. Coury will once again transition his role, this time from his current position of Executive Chairman to Chairman Emeritus and Senior Strategic Advisor to the board and management following the company's 2023 annual meeting of shareholders.

• Kymera Appoints Jeremy Chadwick, Ph.D., as Chief Operating Officer

  5/22/2023

  Kymera Therapeutics, Inc. today announced the appointment of Jeremy Chadwick, Ph.D., as Chief Operating Officer.

• Athira Pharma Appoints Andrew Gengos as Chief Financial Officer and Chief Business Officer

  5/22/2023

  Athira Pharma, Inc. today announced the appointment of Andrew Gengos as Chief Financial Officer and Chief Business Officer, effective immediately.

• G1 Therapeutics Announces Appointment of Monica Thomas as General Counsel

  5/22/2023

  G1 Therapeutics, Inc., a commercial-stage oncology company, announced the appointment of Monica Thomas as its General Counsel and Chief Compliance Officer.

• Repare Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

  5/22/2023

  Repare Therapeutics Inc. today announced that, in connection with the appointment of Daniel Belanger as the Company’s EVP, Human Resources, the Company granted Mr. Belanger an inducement stock option to purchase an aggregate of 240,000 of the Company’s common shares.

• Viatris Announces Appointment of Leo Groothuis to Company's Board of Directors

  5/22/2023

  Viatris Inc. today announced that as part of its ongoing board refreshment efforts, Leo Groothuis has been appointed as Viatris' newest member of its board of directors.

• Angle PLC Announces Board Change - Appointment of New Chairman

  5/22/2023

  ANGLE plc, a world-leading liquid biopsy company announces that Garth Selvey has informed the Board of his intention to retire and leave ANGLE at the publication of the 2023 Interims in September.

• High School Scientists and Engineers Win Nearly $9 Million at the Regeneron International Science and Engineering Fair 2023

  5/19/2023

  Regeneron Pharmaceuticals, Inc. and Society for Science announced that Kaitlyn Wang, 17, of San José, CA, won the $75,000 top award in the 2023 Regeneron International Science and Engineering Fair, the world's largest global pre-college science and engineering competition, for a project that explored planets that orbit very close around their suns.

• ZyVersa Therapeutics Announces Changes to ZyVersa’s Board of Directors

  5/19/2023

  ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA, or “ZyVersa”), a clinical stage specialty biopharmaceutical company developing first-in-class drugs for the treatment of renal and inflammatory diseases with high unmet medical needs, announces that two members of the Board of Directors have stepped down due to obligations associated with recent executive opportunities: Katrin Rupalla, PhD and Daniel O’Connor.

• Zymeworks Announces Departure of Neil Klompas, President and Chief Operating Officer

  5/18/2023

  Zymeworks Inc. today announced the departure of Neil Klompas, President and Chief Operating Officer.

• Replay Appoints Arun Balakumaran M.D., Ph.D as Chief Medical Officer

  5/18/2023

  Replay, a genome writing company reprogramming biology by writing and delivering big DNA, announced the appointment of Arun Balakumaran, M.D., Ph.D., as Chief Medical Officer, effective 22 May.

• Xtant Medical Appoints Lori Mitchell-Keller to Board of Directors

  5/18/2023

  Xtant Medical Holdings, Inc. today announced the appointment of Lori Mitchell-Keller to the Company's Board of Directors effective May 16, 2023.